Peripheral arterial occlusive disease

被引:9
|
作者
Minar, Erich [1 ]
机构
[1] Med Univ Wien, Klin Innere Med 2, Dept Angiol, A-1090 Vienna, Austria
来源
VASA-JOURNAL OF VASCULAR DISEASES | 2007年 / 36卷 / 03期
关键词
peripheral arterial disease; risk factors; antiplatelet treatment; vasoactive drugs; endovascular treatment;
D O I
10.1024/0301-1526.36.3.155
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
This article updates the diagnostic and therapeutic management of petients with peripheral arterial disease.
引用
收藏
页码:155 / 164
页数:10
相关论文
共 50 条
  • [1] PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
    SCHOOP, W
    [J]. HERZ KREISLAUF, 1985, 17 (04): : 167 - 170
  • [2] Peripheral arterial occlusive disease
    Tepohe, G
    [J]. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 1999, 32 (02): : 297 - 297
  • [3] Peripheral arterial occlusive disease (pAOD)
    Karrer, S.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 71 - 71
  • [4] Garlic for peripheral arterial occlusive disease
    Jepson, Ruth G.
    Kleijnen, Jos
    Leng, Gillian C.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (04):
  • [5] Screening for peripheral occlusive arterial disease
    Diehm, C.
    Lawall, H.
    Pittrow, D.
    [J]. GEFASSCHIRURGIE, 2009, 14 (05): : 370 - +
  • [6] Acute peripheral arterial occlusive disease
    Schumann, Romy
    Rieger, Johannes
    Ludwig, Malte
    [J]. MEDIZINISCHE KLINIK, 2007, 102 (06): : 457 - 471
  • [7] Autoantibodies and peripheral arterial occlusive disease
    Kroeger, K
    Kreuzfelder, E
    [J]. HERZ, 2004, 29 (01) : 26 - 31
  • [8] Thrombophilias and peripheral arterial occlusive disease
    Le Hello, C.
    Blacher, J.
    Conard, J.
    Piette, J. -C.
    Constans, J.
    [J]. JOURNAL DES MALADIES VASCULAIRES, 2008, 33 (03) : 126 - 136
  • [9] EVALUATING PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
    BARNES, RW
    [J]. POSTGRADUATE MEDICINE, 1976, 59 (02) : 98 - 103
  • [10] INTRODUCTION - PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
    PILGER, E
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 1985, 135 (15-1) : 359 - 360